Renowned Speakers

Gulsen Meral

Epigenetic Coaching UK

Anuoluwa Ayeni

University of California, San Francisco USA

Sophia Quesada

UC Irvine School of Medicine USA

Maren Beatrice Smith

University of California, Irvine School of Medicine USA

Zachary Penny

North Middlesex University Hospital USA

Recommended Global Reproductive Medicine & Women Healthcare Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

REPRODUCTION FERTILITY 2026

About Conference

The 8th International Conference on Women’s Health, Reproduction and Fertility 2026, will be hosted by Conference Series and is scheduled to take place on November 19–20, 2026, in Singapore. Centered on the theme “Advancing Knowledge and Practice in Women’s Health, Reproductive Science, and Fertility Care” is designed to spotlight critical aspects of reproductive life and women’s health in the context of evolving medical, social, and technological landscapes.

The primary objective of REPRODUCTION FERTILITY 2026 is to provide a dynamic global platform for medical professionals, educators, medical directors, gynaecological oncologists, researchers, and other healthcare practitioners to engage in meaningful discussions and exchange innovative ideas. The conference program will feature insightful keynote lectures, oral and poster presentations, video presentations, exhibitions, symposiums, hands-on workshops, and a dedicated Young Researchers Forum, focusing on the latest advances in reproductive medicine, fertility preservation, and modern contraceptive methods.

Why to Attend?

The 8th International Conference on Women’s Health, Reproduction and Fertility 2026 offers a premier global forum where the organizing committee is curating a highly engaging and educational scientific program. The conference will feature plenary lectures, symposia, interactive workshops, poster sessions, and specialized forums, bringing together leading scientists, clinicians, researchers, healthcare professionals, and exhibitors from around the world to share expertise and explore innovations in reproductive health and fertility.

REPRODUCTION FERTILITY 2026 provides a unique opportunity to participate as a delegate, keynote or oral speaker, panelist, poster or video presenter, as well as to engage in business meetings, collaborative discussions, and high-impact networking sessions. The event highlights cutting-edge techniques, emerging therapies, innovative research findings, and the exchange of novel ideas that are shaping the future of women’s health, reproduction, and fertility care. Additional benefits and visibility opportunities are available for sponsors and exhibitors, making this conference a comprehensive platform for professional growth and collaboration.

Target Audience:

Obstetricians and Gynecologists
Reproductive Endocrinologists and Fertility Specialists
Women’s Health Physicians and Clinicians
Midwives and Nurse Practitioners in Women’s Health
Embryologists and IVF Laboratory Professionals
Public Health Professionals and Epidemiologists
Researchers and Scientists in Reproductive Biology
Maternal and Child Health Specialists
Endocrinologists and Hormone Health Experts
Geneticists and Genomic Medicine Researchers
Fertility Counselors and Psychologists
Nutritionists and Lifestyle Medicine Specialists
Healthcare Policy Makers and Health Administrators
Academicians, Professors, and Medical Educators
Postdoctoral Researchers and Graduate Students
Medical Device and Diagnostic Professionals
NGOs and Organizations Focused on Women’s Health
Clinical Trial Coordinators and Research Associates

Sessions & Tracks

Track 1: Advancing Women’s Health

Emphasizes women’s health as a dynamic and specialized field that evolves across different life stages, from adolescence to older age. It integrates biological, psychological, and socio-cultural determinants of health that uniquely affect women. Strong attention is given to disease prevention, early screening, and long-term management of chronic and non-communicable conditions. This highlight sex-specific risk factors, hormonal transitions, and their implications on long-term well-being.

Focus Areas:

Chronic and lifestyle-related diseases
Cardiovascular health in women
Diabetes and metabolic disorders

World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG) |

Track 2: Reproductive Technologies and Fertility Care

Explores the rapid evolution of assisted reproductive technologies through the integration of precision medicine and digital innovation. It highlights advanced diagnostic tools, personalized fertility treatments, and data-driven clinical decision-making. Emerging applications of artificial intelligence and genomics are discussed for improving reproductive outcomes. Ethical, regulatory, and medico-legal considerations are addressed to ensure responsible adoption of technology.

Focus Areas:

IVF, ICSI, and fertility preservation
Genetic testing and reproductive counseling
Artificial intelligence in fertility prediction
Digital health and medico-legal frameworks

European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI)

Track 3: Stem Cells and Regenerative in Reproductive Medicine

Focuses on the transformative role of regenerative medicine in advancing reproductive healthcare. It examines cutting-edge research in stem cell biology, tissue engineering, and fertility restoration. Discussions include experimental and translational approaches to ovarian, endometrial, and uterine regeneration. And bridges laboratory discoveries with future clinical applications in infertility treatment. Ethical considerations and long-term clinical potential of regenerative therapies are also highlighted.

Focus Areas:

Ovarian and endometrial regeneration
Uterine bioengineering
Germ cell differentiation
Regenerative reproductive surgery

American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS)

Track 4: Fertility and Infertility Management

Addresses infertility as a complex condition influenced by biological, hormonal, genetic, and lifestyle factors. It covers both female and male contributors to reduced reproductive potential. Sessions emphasize early diagnosis, advanced investigations, and personalized treatment strategies. Special focus is given to age-related fertility decline and endocrine disorders.

Focus Areas:

PCOS and endometriosis
Tubal and ovulatory disorders
Male factor infertility
Oocyte quality and ovarian reserve

Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA)

Track 5: Fertility Surgery and IVF Interventions

Presents comprehensive insights into surgical and interventional strategies that support fertility restoration. It highlights advances in reproductive surgery, hormonal modulation, and assisted reproductive technologies. Emphasis is placed on evidence-based IVF protocols and patient-specific treatment planning. Integrated care models for managing complex infertility cases are discussed.

Focus Areas:

Fertility-enhancing surgical procedures
Hormonal and pharmacological therapies
Assisted reproductive technologies and IVF

Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO)

Track 6: Obstetrics, Gynecology, and Maternal Care

This track spans the full continuum of reproductive and maternal healthcare, from conception through postpartum recovery. It emphasizes evidence-based obstetric practices and modern gynecologic management. Innovations in prenatal diagnostics and maternal monitoring are discussed. Sessions also address gynecologic diseases and malignancies impacting women’s health.

Focus Areas:

Antenatal and fetal monitoring
Labor management and cesarean delivery
Postpartum care and maternal recovery
Gynecologic diagnostics and oncology

Track 7: Safe and Effective Drug Management During Pregnancy

Focuses on rational pharmacotherapy during pregnancy, ensuring maternal benefit while safeguarding fetal health. It examines commonly prescribed drugs and their safety profiles across gestation. Evidence-based guidelines and clinical decision-making frameworks are discussed. The track addresses teratogenic risks and drug interactions

Focus Areas:

Antibiotics and analgesics in pregnancy
Antiemetics and antihistamines
Drug safety and fetal development

Track 8: Obstetric Analgesia and Anesthesia

This track is dedicated to pain relief and anesthesia management in obstetric practice. It explores safe and effective labor analgesia techniques and anesthesia for cesarean deliveries. Advances in regional and general anesthesia are highlighted. Multidisciplinary coordination in complex maternal and fetal surgeries is discussed. Patient safety and comfort remain central themes.

Focus Areas:

Labor analgesia strategies
Cesarean anesthesia
Maternal–fetal surgical anesthesia

Track 9: Adolescent and Maternal Health

Addresses reproductive health challenges faced during adolescence and motherhood, particularly in vulnerable populations. It focuses on early pregnancy risks, maternal complications, and preventable health outcomes. Strategies to reduce maternal and neonatal morbidity are discussed. Education, access to care, and public health interventions are emphasized.

Focus Areas:

Adolescent reproductive health
Maternal morbidity and mortality
Family planning and safe motherhood

Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM)

Track 10: Polycystic Ovary Syndrome (PCOS)

An in-depth exploration of PCOS as a multifaceted endocrine and metabolic disorder. It examines its impact on reproductive health, metabolism, and long-term disease risk. Diagnostic challenges and evolving treatment strategies are discussed. Lifestyle, medical, and assisted reproductive interventions are highlighted.

Focus Areas:

Menstrual irregularities and hyperandrogenism
Metabolic and reproductive outcomes
Medical and assisted fertility treatments

Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO)) | American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE)

Track 11: STI’s and Reproductive Health

The burden of sexually transmitted infections and their impact on fertility and reproductive outcomes. It addresses advances in diagnosis, treatment, and prevention strategies. Public health initiatives and patient education are emphasized. The track explores long-term reproductive consequences of untreated infections.

Focus Areas:

Bacterial, viral, and parasitic STIs
HIV and reproductive outcomes
Prevention and sexual health education

Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE)

Track 12: Gynecologic and Reproductive Cancers

Centers on cancers affecting the female reproductive system, with emphasis on early detection and improved outcomes. Advances in screening technologies and diagnostic tools are discussed. Multimodal treatment strategies including surgery, chemotherapy, and targeted therapies are explored. Survivorship care and quality of life are highlighted.

Focus Areas:

Ovarian and uterine cancers
Screening and early diagnosis
Surgical and medical oncology’

International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE)| American College of Obstetricians and Gynecologists (ACOG)

Track 13: Reproductive Endocrinology and Hormonal Health

This track explores hormonal regulation across the reproductive lifespan and its role in fertility and menstrual health. It addresses endocrine disorders affecting ovulation and reproductive function. Clinical and laboratory diagnostic approaches are discussed. Therapeutic strategies including ovulation induction and ART are highlighted.

Focus Areas:

Hormonal axis regulation
Endocrine causes of infertility
Ovulation induction and ART

Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI)| Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO)) American Society for Reproductive Medicine (ASRM)

Track 14: Neuroendocrinology of Reproduction

This track examines the neural control of reproductive function and hormonal signaling pathways. It highlights the role of stress, behavior, and brain–hormone interactions. Transitions such as puberty, pregnancy, and menopause are explored. Psychological and environmental influences on fertility are discussed.

Focus Areas:

Hypothalamic–pituitary–gonadal signaling
Stress-related reproductive disorders
Neuroendocrine transitions across life stages

Track 15: Mental Health in Reproductive and Perinatal Stages

Emphasizes the critical role of mental health in reproductive and perinatal care. It addresses psychological challenges associated with infertility, pregnancy, and postpartum periods. Early identification and intervention strategies are discussed. Integrated mental health services within reproductive care are promoted.

Focus Areas:

Infertility-related stress and anxiety
Perinatal mood disorders
Mental health support in reproductive care

Track 16: Menopause and Healthy Aging in Women

Focuses on the menopausal transition and strategies to promote healthy aging. It addresses symptom management and preventive healthcare interventions. Hormonal and non-hormonal therapies are discussed. Long-term risks related to bone, cardiovascular, and cognitive health are highlighted.

Focus Areas:

Hormone therapy and alternatives
Bone, heart, and cognitive health
Healthy aging strategies

Track 17: Male Factors in Reproductive Medicine

Highlights the importance of male reproductive health in fertility outcomes. It explores diagnostic advancements and treatment strategies for male infertility. Genetic integrity, hormonal regulation, and surgical interventions are discussed. Fertility preservation techniques are emphasized and promotes inclusive, couple-based fertility care.

Focus Areas:

Semen analysis and genetic integrity
Surgical and hormonal treatments
Fertility preservation

Track 18: Microbiome in Women’s Health and Fertility

The influence of the microbiome on reproductive health and fertility. It explores vaginal and gut microbiota interactions with immunity and hormonal balance. Impacts on IVF outcomes and pregnancy are discussed. Novel microbiome-based therapeutic strategies are highlighted. And emphasizes personalized reproductive care.

Focus Areas:

Microbiome and reproductive immunity
IVF outcomes and dysbiosis
Probiotic and microbiome-based therapies

Track 19: Reproductive Immunology and Implantation

Focuses on immune mechanisms regulating implantation and pregnancy success. It explores immune tolerance, inflammation, and endometrial receptivity. Challenges such as recurrent implantation failure are addressed. Emerging immunomodulatory therapies in ART are discussed.

Focus Areas:

Immune–endometrial interactions
Recurrent implantation failure
Immunomodulation in ART

Track 20: Future Innovations in Women’s Health and Fertility

Highlights cutting-edge advancements that are shaping the future of women’s health, fertility, and reproductive medicine. It explores emerging technologies, regenerative therapies, AI-driven diagnostics, genomics, and personalized treatment strategies. Sessions focus on translating research innovations into clinical practice, improving fertility outcomes, maternal care, and overall women’s well-being

Focus Areas:

AI-powered fertility prediction
Genomic-guided reproductive care
Organoid & lab-grown tissue applications

European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynaecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI)

Participation Benefits

Benefits of Participation for Speakers

Gain global recognition and enhance your professional profile among leading researchers.
Earn professional development credits to support career growth.
Showcase your research and explore the latest cutting-edge advancements in your field.
Build long-term connections through structured networking and social activities.
Promote your work with a one-page feature in abstract books and flyers, reaching over 1 million viewers.
Expand your knowledge beyond your core area, exploring new studies and interdisciplinary topics.
Enjoy a unique combination of networking, learning, and engaging experiences in a single package.

Benefits of Participation for Delegates

Enhance professional development and deepen knowledge in your field.
Stay inspired and updated through webinars that rejuvenate and energize participants.
Learn innovative methodologies and ideologies applicable to your work or industry.
Connect with researchers and experts globally to exchange ideas and collaborate.
Gain insights that can broaden perspectives and improve outcomes in your professional practice.

Benefits of Participation for Sponsors

Increase brand visibility and access an international audience for your products or services.
Showcase your company’s latest technologies, innovations, and services to a global network.
Generate business leads and expand opportunities through participant engagement.
Connect with like-minded professionals and organizations to drive growth and collaboration.
Receive valuable feedback and insights to enhance company strategies and offerings.
Benefit from prominent branding on webinar banners, websites, and other marketing materials.
Benchmark industry standards and advance your organizational objectives with expert input.

Benefits of Participation for Collaborators/Associates

Increase your subscriber or member base by up to 40% through event promotion and branding.
Gain global exposure for your organization through listings in international business forums.
Empower your representatives to network and update knowledge with key delegates.
Distribute marketing materials, including posters, brochures, and pamphlets, to hospitals, universities, societies, and researchers.
Strengthen your organization’s visibility and influence in the professional community

Market Analysis

Scope and Importance

The primary goal of statistical research in reproductive health is to enhance public awareness of critical issues, identify unmet needs, and drive meaningful improvements in healthcare delivery. The 2026 International Conference on Women’s Health, Reproduction, and Fertility will focus on comprehensive discussions surrounding reproductive health, offering detailed insights into the latest approaches for managing gynecological cancers, pregnancy care, PCOS, sexually transmitted infections, infertility, and more. This conference aims to provide a platform for clinicians, researchers, and healthcare professionals to exchange knowledge, explore innovative treatments, and advance strategies that improve women’s health globally.

Women’s Health Market

In 2024, the global population was 6.15 billion, with women accounting for approximately 49.7%. By 2026, the world population is expected to reach 8.19 billion, with women representing 49.5%, highlighting the sustained demand for women-focused healthcare solutions. Women typically outlive men and experience faster hormonal, physical, and emotional changes throughout their lifespan, driving the need for improved healthcare and educational services.

The global market for women’s health pharmaceuticals has shown steady growth, expanding from over $33.0 billion in 2023 to an estimated $40.6 billion by 2024, at a CAGR of 4.2%. Sophisticated analyses project that the global women’s health market will reach approximately USD 5.13 billion by 2025. Independent studies estimate growth from $30.88 billion in 2016 to more than $51.3 billion by 2025, reflecting a CAGR of 5.85%, underscoring the market’s significant potential.

Fertility Services Market

Fertility services encompass a range of specialized treatments addressing reproductive and genetic challenges, including assisted reproductive technologies (ART) that support couples and individuals worldwide. The global fertility services market was valued at $16.76 billion in 2016 and is projected to grow to $30.96 billion by 2023, at a CAGR of 9.3%. The IVF segment alone generated $10.59 billion in 2017 and is expected to reach $22.47 billion by 2025, growing at a CAGR of 9.8%. The fertility medications market is projected to rise from $3.4 billion in 2017 to $4.2 billion by 2022, growing at a CAGR of 4.3%. Additionally, the global contraceptive market, valued at $19.8 billion in 2015, is expected to reach $33.6 billion by 2023, driven by increasing awareness, rising STD cases, and the demand for family planning solutions.

Related Associations and Societies

Middle East: Middle East Fertility Society (MEFS) | Syrian American Medical Society | Iranian Scientific Association of Embryology and Reproductive Biology | Iranian Scientific Association of Endocrinology | Iranian Scientific Association of Reproductive Medicine | Turkish Society of Obstetrics & Gynecology | Turkish Society for Reproductive Medicine | Turkish Infertility Foundation | Turkish Medical Association | Iraqi Society of Obstetrics & Gynecology (ISOG) | Saudi Society of Obstetrics & Gynecology | Saudi Obstetrical and Gynecological Society | Saudi Gynecology Oncology Group

USA: American Association of Gynecologic Laparoscopists | American College of Obstetricians & Gynecologists (ACOG) | Association of Physician Assistants in Obstetrics and Gynecology | Association of Professors of Gynecology and Obstetrics | Central Association of Obstetricians and Gynecologists | Gynecologic Cancer Foundation | Society of Gynecologic Oncologists (SGO) | International Urogynecological Association (IUGA) | American Osteopathic Board of Obstetrics and Gynecology | American Society for Reproductive Medicine (ASRM)

Europe: European Society of Contraception and Reproductive Health | German Foundation for World Population | European Association of Pediatric and Adolescent Gynecology | Italian Society for Obstetrics and Gynecology | European Board & College of Obstetrics and Gynecology | European Society of Gynecological Oncology | Austrian Society of Sterility, Infertility and Endocrinology | Croatian Society of Gynecological Endoscopy | German Society of Gynecological and Obstetrical Endoscopy

Past Conference Report

A heartfelt thank you to all our exceptional keynote speakers, presenters, attendees, students, associations, media partners, and visitors REPRODUCTION FERTILITY 2026 is set to be an extraordinary event! The 8th International Conference on Women's Health, Reproduction and Fertility, taking place on November 19–20, 2026, in Singapore, promises to be a premier platform for sharing knowledge and advancing research in women’s health and reproductive medicine.

This conference will bring together leading experts, researchers, clinicians, scientists, young investigators, industrialists, and students from around the world to discuss the latest innovations and breakthroughs in the field. The program will feature inspiring keynote speeches, interactive sessions, and collaborative networking opportunities designed to foster learning and professional growth.

Join us as we explore cutting-edge research, exchange ideas, and continue the conversation on leading a healthy reproductive life at REPRODUCTION FERTILITY 2026 in Singapore!

To Collaborate Scientific Professionals around the World

Conference Date November 19-20, 2026

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Supported By

Gynecology & Obstetrics Journal of Womens Health, Issues and Care Journal of Pregnancy and Child Health

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Womens Health, Reproduction and Fertility

November 19-20, 2026 Singapore City, Singapore

Conference Series Conferences gaining more Readers and Visitors

Renowned Speakers

Gulsen Meral

Anuoluwa Ayeni

Sophia Quesada

Maren Beatrice Smith

Zachary Penny

Recommended Global Reproductive Medicine & Women Healthcare Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

REPRODUCTION FERTILITY 2026

About Conference

Sessions & Tracks

Participation Benefits

Market Analysis

Past Conference Report

To Collaborate Scientific Professionals around the World

Useful Links

Supported By